The Latest Breaking News from Abbott

The diabetes donnybrook between Abbott Laboratories and Dexcom is poised to heat up — and could bolster both Abbott stock and Dexcom stock.

British group says claims products cause serious bowel condition NEC are ‘not supported by science’

Abbott stock slumped Thursday despite offering a "clean print" that includes strong growth for its diabetes business and a guidance boost.

Abbott is poised to release its second-quarter results this month, and analysts are projecting a slight increase in profits.

The S&P 500 index’s 2024 rally continued in June as solid corporate earnings outweighed concerns over slower economic growth and a potential delay in the Fed’s pivot to interest rate cuts. Further, several Wall Street strategists raised their year-end S&P 500 price targets. Hence, top-performing S&P 500 stocks Amazon.com (AMZN),…

The U.S. Food and Drug Administration took 15 months to act on a whistleblower complaint about the Abbott Nutrition factory at the center 2022's nationwide infant formula shortage

Abbott Laboratories gained U.S. clearance Monday for a pair of new CGMs. But Abbott stock fell a fraction at the close.

Despite Abbott’s recent underperformance over the past year, Wall Street analysts remain optimistic about the stock’s prospects.

An apparent glitch at the operator of the New York Stock Exchange triggered volatility trading halts shortly after the open in about a dozen companies, including Chipotle Mexican Grill Inc. and Abbott Laboratories.